Clinical Trials Browser

Phase 2 × Interventional × Chemotherapy-Induced Peripheral Neuropathy × Clear all

NCT05388058 2026-01-16

Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy

Phase 2 Completed

40 enrolled 15 charts

OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy